BioSpace News Archive

Drug Development

Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China

Hutchison China MediTech Limited has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in combination with azacitidine, an approved nucleoside metabolic inhibitor, in elderly patients with acute myeloid leukemia (“AML”) in China.

October 23, 2018
·
4 min read
Job Trends

10 Months After Abandoning Neuroscience R&D, Pfizer Launches CNS Company Cerevel Therapeutics

Pharma giant Pfizer and Bain Capital teamed up to launch Cerevel Therapeutics, a new biopharmaceutical company based in Boston that will focus on developing therapies to treat central nervous system disorders.

October 23, 2018
·
3 min read
·
Alex Keown
Drug Development

Eli Lilly Updates Spondyloarthritis Trial Data and Long-Term Rheumatoid Arthritis Studies

Eli Lilly and Company presented positive data from two Phase III clinical trials at the American College of Rheumatology (ACR)/Association of Rheumatology Health Professionals (ARHP) Annual Meeting in Chicago yesterday.

October 23, 2018
·
3 min read
·
Mark Terry
Business

Celgene Brings in Merck KGaA Vet as Part of an Effort to Fix Clinical Development Woes

Following several clinical disappointments and declining stock prices over the past year, Celgene tapped Alise Reicin as its new head of the company’s global clinical development unit, with a focus on mid- to late-stage therapeutics.

October 23, 2018
·
2 min read
·
Alex Keown
Drug Development

Enanta Pharmaceuticals Announces Positive Phase 1 Results and Initiation of Phase 2a Clinical Study of EDP-938 for Respiratory Syncytial Virus

Study to evaluate the safety, pharmacokinetics and antiviral activity of multiple doses of orally administered EDP-938 against respiratory syncytial virus infection in a human challenge study.

October 23, 2018
·
6 min read
Business

Millar Completes Exit from Telemetry Product Sales and Transitions to Life Sciences OEM Partnership Model

Millar, Inc. today announces the company will finalize its exit from the life sciences telemetry market on December 31, 2018.

October 23, 2018
·
2 min read
Lone Star Bio

Virginia Premier Selects Jiva to Help Streamline Workflows and Heighten Efficiencies

Virginia Premier recently selected Jiva 6.1, the end-to-end population health management platform from ZeOmega, to enhance health services for its approximately 220,000 members.

October 23, 2018
·
3 min read
DarioHealth’s Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max

Analyst estimates 75-80 Million iPhone Shipments in 2H 2018

October 23, 2018
·
3 min read
New Clinical Research Shows the Safety, Tolerability and Efficacy of the Epitomee Capsule

12 weeks of treatment with the Epitomee Capsule resulted in meaningful weight loss, accompanied by improvement in several cardio-metabolic parameters. The novel Epitomee Capsule treatment is well tolerated and has a favorable safety profile without related SAE.

October 23, 2018
·
2 min read
Genetown

New Study Showcases Improved Survival With More Frequent Home Hemodialysis in Incident Dialysis Patients

Patients 20-44 years of age experienced 44% lower risk of death

October 23, 2018
·
5 min read